CCAR-168 is under clinical development by AbelZeta and currently in Phase I for Lupus Nephritis. According to GlobalData, Phase I drugs for Lupus Nephritis have an 84% phase transition success rate ...
Nick Cannon opened up about his lupus diagnosis during a new house tour of his ‘Cannon Estate,’ comparing his lupus journey to Tony Stark’s life while showing off his Louis Vuitton Iron Man helmet.